Skip to main content

Myelodysplastic Syndromes (MDS) VA Disability Rating

Diagnostic code 7725
By the editorial deskUpdated Jun 13, 2026Sources verified Jun 13, 2026
Presumptive under: PACT Act Camp Lejeune
Quick summary
Myelodysplastic syndromes are rated under diagnostic code 7725: 100 percent when a stem cell transplant or chemotherapy is required, 60 percent for 4 or more transfusions per year or 3 or more hospitalizations for infection, and 30 percent for 1 to 3 transfusions per year, 1 to 2 infection hospitalizations, or ongoing biologic therapy. MDS appears on the Camp Lejeune presumptive list and VA added it to the burn pit presumptions in 2025.
Key requirements
  • Service connection requires a current diagnosis, an in-service event or exposure, and a medical link (nexus) between the two.
  • VA assigns ratings of 30% to 100% under diagnostic code 7725, using the criteria in the rating table below.
  • The percentage assigned turns on Transfusions, infections, and treatment.
  • Presumptive service connection may apply under the PACT Act and the Camp Lejeune for veterans with qualifying service.
This page explains common evidence VA may consider when rating this condition. It is not medical advice and does not diagnose any condition. Talk with a licensed medical professional about diagnosis and treatment, and with a VA accredited representative (38 CFR 14.629) about a specific claim.
Ratings
30% to 100%
Diagnostic code
7725
Decided on
Transfusions, infections, and treatment
Presumptive under
PACT Act, Camp Lejeune
The five parts of a compensation decisionA current disabilityAn in service eventA connectionSeverity under the criteriaAn effective dateHow the pieces fit together
RatingCriteria
30%Requiring at least 1 but no more than 3 blood or platelet transfusions per 12 month period; infections requiring hospitalization at least 1 but no more than 2 times per 12 month period; or requiring biologic therapy on an ongoing basis or erythropoiesis stimulating agent for 12 weeks or less per 12 month period.
60%Requiring 4 or more blood or platelet transfusions per 12 month period; or infections requiring hospitalization 3 or more times per 12 month period.
100%Requiring peripheral blood or bone marrow stem cell transplant; or requiring chemotherapy.

Illustrative scenarios showing how the criteria above are applied. These are educational examples, not a prediction of any individual veteran's rating.

Occasional transfusions or infections

Illustrates 30%

Situation. MDS needs one to three transfusions a year, or causes one to two infection hospitalizations a year, or needs ongoing biologic therapy.

How the criteria apply. 1 to 3 transfusions a year, 1 to 2 infection hospitalizations a year, or ongoing biologic/erythropoiesis-stimulating therapy rate 30 percent under DC 7725.

Frequent transfusions or infections

Illustrates 60%

Situation. Four or more transfusions a year, or three or more infection hospitalizations a year.

How the criteria apply. 4 or more transfusions a year, or 3 or more infection hospitalizations a year, rate 60 percent under DC 7725.

The rating runs on how much support the bone marrow failure needs: transplant or chemo at the top, then transfusions and infection hospitalizations. Keep a count of every transfusion, because the tiers are literal.

What VA looks at

Bone marrow biopsy confirming MDS, the transfusion and infection record over the past 12 months, treatment type, and qualifying service for the presumptions.

Common exam and DBQ topics

Transfusion frequency, infections, fatigue, treatment plan, transplant candidacy.

Evidence that usually matters

Bone marrow biopsy reports, hematology notes, transfusion logs, hospitalization records, service records.

Common misunderstandings

If MDS progresses to leukemia, the rating switches to diagnostic code 7703 at 100 percent. The 100 percent transplant rating runs from hospital admission and holds until a mandatory examination 6 months after discharge.

If a VA decision on this came back wrong

You have three review lanes, pick the one that fits the situation.

Under the Appeals Modernization Act, a veteran has one year from a VA decision to file a Higher Level Review, a Supplemental Claim, or a Board Appeal, and filing within that one year window protects the original effective date.

Related conditions

Background reading

Supplemental articles that connect to this condition.

State benefits stack with VA disability

Your rating may also qualify you for state-level benefits.

VA compensation is federal, but every state layers its own benefits on top. Many states reduce or waive property tax for disabled veterans, and many offer license, tuition, or vehicle benefits at various rating levels. The thresholds, dollar amounts, and eligibility rules vary widely from state to state, so the reliable answer is always your own state's guide.

See your state's benefitsReviewed quarterly

Put this rating to work

Free calculators and a guide to turn a rating percentage into real numbers. Nothing is saved to a server; your figures stay on your device.

Secondary conditions and case specific outcomes are fact specific. We do not tell you what claims to file. Consider talking with a VA accredited representative.
Was this page helpful?
Editor's note

Most recent human review on this page, July 5, 2026. Below is the review history across this page, its citations, and the supplemental articles it links to.

  1. July 5, 2026articleAppealing or Continuing a VA Decision: The Three Lanes Under the AMA
  2. July 5, 2026articlePACT Act and Gulf War Claims
  3. July 5, 2026articleThe C&P Exam: What to Expect and How to Prepare
  4. July 5, 2026articleVA Presumptive Conditions, Category by Category
  5. June 13, 2026conditionThis page
  6. June 13, 2026citation38 CFR Part 4 Schedule for Rating Disabilities
Printed from The Veteran Benefit Desk - https://veteranbenefitdesk.com/conditions/myelodysplastic-syndromes. Figures reflect this page as published. Rates change each December; confirm current amounts at veteranbenefitdesk.com before relying on them.
We use only strictly necessary, first-party cookies. No advertising or cross-site tracking cookies run on this site. We use limited first-party, cookieless measurement to understand site performance and prevent abuse: no third-party pixels, no ad profiling, and no selling or sharing of personal information for behavioral advertising. We honor Global Privacy Control signals automatically, and if we ever add optional cookies, the choice you save here will govern them. Read our Privacy Policy.